North America Neurostimulation Devices Market By Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices) By Applications (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The North America Neurostimulation Devices Market would witness market growth of 11.8% CAGR during the forecast period (2020-2026).
Neuromodulation is an interesting topic that is an important part of pain and other diseases. In many ways, the future of neuromodulation is evolving and growing, including understanding the pathways driving action and the possible role that digital medicine has in chronic disease treatment.
In the last two decades, the technological advancements in the technology have been impressive, yet the progress made in cardiovascular electrical therapy is not as significant because of the lack of funding and collaboration. Currently, neuromodulation technology is still considered to be in its infancy, but the last few years have seen some significant improvements in hardware, software, and conceptual advances to the core of the field. The long-term future will depend on innovation, investment, stabilization, and oversight by government agencies and high-level evidence.
The growth of the market for neurostimulation devices is driven by factors such as increasing the prevalence of lifestyle diseases like depression and chronic pain and increasing numbers of neurological disorders and investment in R&D. In addition, increasing demand for a minimally invasive procedure, adoption of advanced technological products, and the rise in the elderly population also stimulate market growth since they are more sensitive to neurological conditions such as Epilepsy, Parkinson's disease, Alzheimer's and chronic pain.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
Neuromodulation is an interesting topic that is an important part of pain and other diseases. In many ways, the future of neuromodulation is evolving and growing, including understanding the pathways driving action and the possible role that digital medicine has in chronic disease treatment.
In the last two decades, the technological advancements in the technology have been impressive, yet the progress made in cardiovascular electrical therapy is not as significant because of the lack of funding and collaboration. Currently, neuromodulation technology is still considered to be in its infancy, but the last few years have seen some significant improvements in hardware, software, and conceptual advances to the core of the field. The long-term future will depend on innovation, investment, stabilization, and oversight by government agencies and high-level evidence.
The growth of the market for neurostimulation devices is driven by factors such as increasing the prevalence of lifestyle diseases like depression and chronic pain and increasing numbers of neurological disorders and investment in R&D. In addition, increasing demand for a minimally invasive procedure, adoption of advanced technological products, and the rise in the elderly population also stimulate market growth since they are more sensitive to neurological conditions such as Epilepsy, Parkinson's disease, Alzheimer's and chronic pain.
Based on Devices, the market is segmented into Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices. Based on Applications, the market is segmented into Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Nevro Corporation, Medtronic PLC, NeuroSigma, Inc., Integer Holdings Corporation, LivaNova PLC, NeuroPace, Inc., Neuronetics, Inc., and Synapse BioMedical, Inc.
Scope of the Study
Market Segmentation:
By Devices
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators and
- Other Devices
- Pain Management
- Hearing Loss
- Urinary Incontinence
- Parkinson's Disease
- Epilepsy and
- Other Applications
- US
- Canada
- Mexico
- Rest of North America
- Abbott Laboratories
- Boston Scientific Corporation
- Nevro Corporation
- Medtronic PLC
- NeuroSigma, Inc.
- Integer Holdings Corporation
- LivaNova PLC
- NeuroPace, Inc.
- Neuronetics, Inc.
- Synapse BioMedical, Inc.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neurostimulation Devices Market, by Devices
1.4.2 North America Neurostimulation Devices Market, by Applications
1.4.3 North America Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 North America Spinal Cord Stimulators Market by Country
4.2 North America Deep Brain Stimulators Market by Country
4.3 North America Sacral Nerve Stimulators Market by Country
4.4 North America Vagus Nerve Stimulators Market by Country
4.5 North America Other Devices Market by Country
CHAPTER 5. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 North America Pain Management Market by Country
5.2 North America Hearing Loss Market by Country
5.3 North America Urinary Incontinence Market by Country
5.4 North America Parkinson's Disease Market by Country
5.5 North America Epilepsy Market by Country
5.6 North America Other Applications Market by Country
CHAPTER 6. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 US Neurostimulation Devices Market
6.1.1 US Neurostimulation Devices Market by Devices
6.1.2 US Neurostimulation Devices Market by Applications
6.2 Canada Neurostimulation Devices Market
6.2.1 Canada Neurostimulation Devices Market by Devices
6.2.2 Canada Neurostimulation Devices Market by Applications
6.3 Mexico Neurostimulation Devices Market
6.3.1 Mexico Neurostimulation Devices Market by Devices
6.3.2 Mexico Neurostimulation Devices Market by Applications
6.4 Rest of North America Neurostimulation Devices Market
6.4.1 Rest of North America Neurostimulation Devices Market by Devices
6.4.2 Rest of North America Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neurostimulation Devices Market, by Devices
1.4.2 North America Neurostimulation Devices Market, by Applications
1.4.3 North America Neurostimulation Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES
4.1 North America Spinal Cord Stimulators Market by Country
4.2 North America Deep Brain Stimulators Market by Country
4.3 North America Sacral Nerve Stimulators Market by Country
4.4 North America Vagus Nerve Stimulators Market by Country
4.5 North America Other Devices Market by Country
CHAPTER 5. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS
5.1 North America Pain Management Market by Country
5.2 North America Hearing Loss Market by Country
5.3 North America Urinary Incontinence Market by Country
5.4 North America Parkinson's Disease Market by Country
5.5 North America Epilepsy Market by Country
5.6 North America Other Applications Market by Country
CHAPTER 6. NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY
6.1 US Neurostimulation Devices Market
6.1.1 US Neurostimulation Devices Market by Devices
6.1.2 US Neurostimulation Devices Market by Applications
6.2 Canada Neurostimulation Devices Market
6.2.1 Canada Neurostimulation Devices Market by Devices
6.2.2 Canada Neurostimulation Devices Market by Applications
6.3 Mexico Neurostimulation Devices Market
6.3.1 Mexico Neurostimulation Devices Market by Devices
6.3.2 Mexico Neurostimulation Devices Market by Applications
6.4 Rest of North America Neurostimulation Devices Market
6.4.1 Rest of North America Neurostimulation Devices Market by Devices
6.4.2 Rest of North America Neurostimulation Devices Market by Applications
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
LIST OF TABLES
TABLE 1 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 NORTH AMERICA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 NORTH AMERICA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 NORTH AMERICA OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 NORTH AMERICA OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 US NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 US NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 US NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 US NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 US NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 US NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 CANADA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 CANADA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 MEXICO NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 MEXICO NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 60 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 61 KEY INFORMATION – NEVRO CORPORATION
TABLE 62 KEY INFORMATION – MEDTRONIC PLC
TABLE 63 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 64 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 65 KEY INFORMATION – LIVANOVA PLC
TABLE 66 KEY INFORMATION – NEUROPACE, INC.
TABLE 67 KEY INFORMATION – NEURONETICS, INC.
TABLE 68 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
TABLE 1 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEUROSTIMULATION DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– NEUROSTIMULATION DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEUROSTIMULATION DEVICES MARKET
TABLE 6 APPROVALS – NEUROSTIMULATION DEVICES MARKET
TABLE 7 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 8 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 9 NORTH AMERICA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 NORTH AMERICA SPINAL CORD STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 NORTH AMERICA DEEP BRAIN STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 NORTH AMERICA SACRAL NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 16 NORTH AMERICA VAGUS NERVE STIMULATORS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 17 NORTH AMERICA OTHER DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 NORTH AMERICA OTHER DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 20 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 21 NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 NORTH AMERICA PAIN MANAGEMENT MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 NORTH AMERICA HEARING LOSS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 NORTH AMERICA HEARING LOSS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 NORTH AMERICA URINARY INCONTINENCE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 NORTH AMERICA PARKINSON'S DISEASE MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 30 NORTH AMERICA EPILEPSY MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 31 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 32 NORTH AMERICA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 33 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 34 NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 35 US NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 US NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 US NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 38 US NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 39 US NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 40 US NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 41 CANADA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 CANADA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 44 CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 45 CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 46 CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 47 MEXICO NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 MEXICO NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 50 MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 51 MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 52 MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 53 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2016 - 2019, USD MILLION
TABLE 56 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICES, 2020 - 2026, USD MILLION
TABLE 57 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2016 - 2019, USD MILLION
TABLE 58 REST OF NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATIONS, 2020 - 2026, USD MILLION
TABLE 59 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 60 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 61 KEY INFORMATION – NEVRO CORPORATION
TABLE 62 KEY INFORMATION – MEDTRONIC PLC
TABLE 63 KEY INFORMATION – NEUROSIGMA, INC.
TABLE 64 KEY INFORMATION – INTEGER HOLDINGS CORPORATION
TABLE 65 KEY INFORMATION – LIVANOVA PLC
TABLE 66 KEY INFORMATION – NEUROPACE, INC.
TABLE 67 KEY INFORMATION – NEURONETICS, INC.
TABLE 68 KEY INFORMATION – SYNAPSE BIOMEDICAL, INC.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: LIVANOVA PLC
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: NEUROPACE, INC.
